We are live on ! Find out more
NPCE icon

Neuropace
NPCE

54 hedge funds and large institutions have $176M invested in Neuropace in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $381K | Put options by funds: $99K

260% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 5

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

32% more funds holding

Funds holding: 41 → 54 (+13)

13% more capital invested

Capital invested by funds: $156M → $176M (+$20.2M)

10.51% less ownership

Funds ownership: 57.65% → 47.15% (-11%)

Holders
54
Holders Change
+13
Holders Change %
+31.71%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
18
Increased
19
Reduced
13
Closed
5
Calls
$381K
Puts
$99K
Net Calls
+$282K
Net Calls Change
+$282K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$6.18M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.3M
3
Goldman Sachs
Goldman Sachs
New York
+$1.99M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.08M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$673K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$34.8M
2
NCM
Nantahala Capital Management
Connecticut
-$5.64M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.36M
4
KLC
Kent Lake Capital
Nevada
-$390K
5
Bank of America
Bank of America
North Carolina
-$260K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$391K -$77.4K -5,428 -15%
MTIM
27
Marathon Trading Investment Management
Pennsylvania
$370K +$399K +28,000 New
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$356K -$2.94K -206 -0.8%
JF
29
Jump Financial
Illinois
$337K +$364K +25,538 New
PTC
30
Petrus Trust Company
Texas
$316K +$341K +23,904 New
LCM
31
Laurion Capital Management
New York
$273K – – –
Walleye Capital
32
Walleye Capital
New York
$260K +$76.7K +5,378 +38%
ECM
33
ExodusPoint Capital Management
New York
$256K -$5.13K -360 -2%
BAM
34
Bosun Asset Management
Illinois
$244K +$264K +18,499 New
XT
35
XTX Topco
Cayman Islands
$203K +$220K +15,412 New
BHCM
36
Brevan Howard Capital Management
Jersey
$198K +$214K +15,034 New
SSA
37
Schonfeld Strategic Advisors
New York
$190K +$206K +14,426 New
Barclays
38
Barclays
United Kingdom
$183K -$1.44K -101 -0.7%
Bank of America
39
Bank of America
North Carolina
$181K -$260K -18,199 -57%
Squarepoint
40
Squarepoint
New York
$176K +$190K +13,316 New
HIM
41
Hillsdale Investment Management
Ontario, Canada
$155K +$168K +11,750 New
JFG
42
Jefferies Financial Group
New York
$144K +$155K +10,900 New
YIH
43
Y-Intercept (HK)
Hong Kong
$138K +$150K +10,491 New
PAS
44
Point72 Asia (Singapore)
Singapore
$137K +$144K +10,122 +3,939%
FAIM
45
Financial Advocates Investment Management
Washington
$132K – – –
Citadel Advisors
46
Citadel Advisors
Florida
$108K -$227K -15,905 -66%
TRCT
47
Tower Research Capital (TRC)
New York
$49.7K +$50.1K +3,511 +1,393%
Lazard Asset Management
48
Lazard Asset Management
New York
$46K -$5.53K -388 -10%
Wells Fargo
49
Wells Fargo
California
$27.5K +$28.5K +2,001 +2,470%
UBS Group
50
UBS Group
Switzerland
$22.4K +$24.2K +1,700 New
1
2
3

NPCE Hedge Fund Activity: Q1 2024 in Review

54 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q1 2024, worth a combined $176M — up 13% from $156M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new NPCE positions and 5 closed out — a net gain of 13 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Millennium Management, adding an estimated $6.18M. The largest seller was Morgan Stanley, cutting an estimated $34.8M.

  • 54 institutional investors held Neuropace (NPCE) as of Q1 2024, up from 41 in Q4 2023.
  • Funds reported $176M of Neuropace stock for Q1 2024, up 13% quarter-over-quarter.
  • 18 funds opened new Neuropace positions in Q1 2024 and 5 closed out, a net change of +13 holders.
  • The largest Neuropace buyer in Q1 2024 was Millennium Management, an estimated $6.18M added.
  • The largest Neuropace seller in Q1 2024 was Morgan Stanley, an estimated $34.8M sold.

Based on aggregated 13F filings for Q1 2024.